IOVA
IOVANCE BIOTHERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$14.21
+4.33%Margins
Gross margin
48.4%
EBITDA margin
-77.3%
EBIT margin
-91.1%
Net margin
-89.1%
FCF margin
-91.2%
-39.3%
Return on equity
-31.6%
Return on assets
-37.9%
Return on invested capital
0.35x
Asset turnover
-$264.2M
Cash from operations
$0.66
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026